WallStreetZenWallStreetZen

NASDAQ: PSTV
Plus Therapeutics Inc Stock Ownership - Who owns Plus Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Plus Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrew John Hugh Macintyre SimsChief Financial Officer2025-11-0420,000$0.51
$10.20kBuy
Robert P. LenkDirector2025-08-22110,000$0.49
$53.79kBuy

1 of 1

PSTV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PSTV insiders and whales buy or sell their stock.

PSTV Shareholders

What type of owners hold Plus Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kian Thiam Lim107.51%7,400,000$29.60MInsider
Bank Sa Swissquote77.41%5,328,229$21.31MInsider
Ag Postfinance66.00%4,543,086$18.17MInsider
Olympus Corp58.30%4,013,043$16.05MInsider
Vanguard Capital Management LLC35.26%2,427,098$9.71MInstitution
Geode Capital Management LLC29.29%2,016,314$8.07MInstitution
Blackrock Inc25.81%1,776,372$7.11MInstitution
Vanguard Fiduciary Trust Co16.91%1,163,776$4.66MInstitution
State Street Corp6.81%468,893$1.88MInstitution
Marshall G. Cox6.06%417,050$1.67MInsider

1 of 3

PSTV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PSTV28.02%71.98%Net Buying
IGC4.33%25.77%Net BuyingNet Buying
TAOX6.29%3.37%Net Selling
QCLS7.51%92.49%Net Buying
EVAX0.37%5.19%
View Top Biotech Stocks

Plus Therapeutics Stock Ownership FAQ

Who owns Plus Therapeutics?

Plus Therapeutics (NASDAQ: PSTV) is owned by 132.78% institutional shareholders, 341.02% Plus Therapeutics insiders, and 0.00% retail investors. Kian Thiam Lim is the largest individual Plus Therapeutics shareholder, owning 7.40M shares representing 107.51% of the company. Kian Thiam Lim's Plus Therapeutics shares are currently valued at $29.60M.

If you're new to stock investing, here's how to buy Plus Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.